Market Closed -
Nyse
01:40:00 13/06/2024 am IST
|
5-day change
|
1st Jan Change
|
0.6926
USD
|
-6.41%
|
|
+1.85%
|
-3.40%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
194.8
|
187.5
|
168.1
|
139.8
|
56.42
|
57.36
|
-
|
-
|
Enterprise Value (EV)
1 |
181.4
|
187.5
|
168.1
|
139.8
|
56.42
|
52.96
|
31.46
|
27.06
|
P/E ratio
|
-11.6
x
|
-8.64
x
|
-6.16
x
|
-4.42
x
|
-1.43
x
|
-1.9
x
|
-2.73
x
|
-8.15
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
11,391
x
|
13,960
x
|
1,867
x
|
456
x
|
72.8
x
|
20.1
x
|
4.26
x
|
1.41
x
|
EV / Revenue
|
10,606
x
|
13,960
x
|
1,867
x
|
456
x
|
72.8
x
|
18.6
x
|
2.33
x
|
0.66
x
|
EV / EBITDA
|
-11.5
x
|
-9.13
x
|
-
|
-5.04
x
|
-1.73
x
|
-1.8
x
|
-1.22
x
|
-2.26
x
|
EV / FCF
|
-
|
-10.2
x
|
-7.7
x
|
-
|
-
|
-1.95
x
|
-2.31
x
|
5.11
x
|
FCF Yield
|
-
|
-9.82%
|
-13%
|
-
|
-
|
-51.3%
|
-43.4%
|
19.6%
|
Price to Book
|
13.7
x
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
41,092
|
48,198
|
53,536
|
57,521
|
78,686
|
82,824
|
-
|
-
|
Reference price
2 |
4.740
|
3.890
|
3.140
|
2.430
|
0.7170
|
0.6926
|
0.6926
|
0.6926
|
Announcement Date
|
20/02/20
|
22/03/21
|
30/03/22
|
15/03/23
|
25/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
0.0171
|
0.0134
|
0.09
|
0.3064
|
0.7753
|
2.855
|
13.48
|
40.72
|
EBITDA
1 |
-15.83
|
-20.53
|
-
|
-27.73
|
-32.55
|
-29.4
|
-25.7
|
-12
|
EBIT
1 |
-16.04
|
-21.25
|
-28.33
|
-31.78
|
-35.99
|
-30.83
|
-21.27
|
-4.95
|
Operating Margin
|
-93,818.25%
|
-1,58,211.62%
|
-31,467.21%
|
-10,372.42%
|
-4,641.78%
|
-1,079.98%
|
-157.76%
|
-12.16%
|
Earnings before Tax (EBT)
1 |
-16.1
|
-20.4
|
-26.99
|
-30.6
|
-35.68
|
-31.07
|
-21.5
|
-5.15
|
Net income
1 |
-16.1
|
-20.35
|
-26.81
|
-30.27
|
-35.32
|
-32.03
|
-22.5
|
-6.9
|
Net margin
|
-94,146.55%
|
-1,51,542.22%
|
-29,780.84%
|
-9,879.17%
|
-4,555.54%
|
-1,121.84%
|
-166.91%
|
-16.94%
|
EPS
2 |
-0.4100
|
-0.4500
|
-0.5100
|
-0.5500
|
-0.5000
|
-0.3650
|
-0.2533
|
-0.0850
|
Free Cash Flow
1 |
-
|
-18.41
|
-21.83
|
-
|
-
|
-27.15
|
-13.65
|
5.3
|
FCF margin
|
-
|
-1,37,046.17%
|
-24,241.98%
|
-
|
-
|
-950.96%
|
-101.26%
|
13.02%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20/02/20
|
22/03/21
|
30/03/22
|
15/03/23
|
25/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
0.0142
|
0.1142
|
0.0398
|
0.0327
|
0.1197
|
0.1498
|
0.2163
|
0.1652
|
0.244
|
0.1715
|
0.5075
|
0.8238
|
1.364
|
1.3
|
1.8
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-8.079
|
-
|
-7.819
|
-7.978
|
-7.71
|
-7.5
|
-7.3
|
-6.9
|
-
|
-
|
EBIT
1 |
-8.785
|
-7.677
|
-8.099
|
-7.993
|
-8.011
|
-9.045
|
-9.549
|
-8.653
|
-8.741
|
-8.384
|
-7.967
|
-7.467
|
-6.967
|
-6.4
|
-5.6
|
Operating Margin
|
-61,692.56%
|
-6,721.81%
|
-20,376.05%
|
-24,435.83%
|
-6,691.16%
|
-6,037.67%
|
-4,414.52%
|
-5,237.61%
|
-3,582.64%
|
-4,887.78%
|
-1,569.79%
|
-906.42%
|
-510.67%
|
-492.31%
|
-311.11%
|
Earnings before Tax (EBT)
1 |
-8.21
|
-7.718
|
-7.732
|
-7.812
|
-7.336
|
-8.873
|
-9.551
|
-8.453
|
-8.8
|
-8.472
|
-8
|
-7.533
|
-7.033
|
-6.4
|
-5.6
|
Net income
1 |
-7.933
|
-7.634
|
-7.65
|
-7.743
|
-7.242
|
-8.78
|
-9.471
|
-8.37
|
-8.698
|
-8.367
|
-8.257
|
-7.895
|
-7.344
|
-6.4
|
-5.6
|
Net margin
|
-55,710.04%
|
-6,684.2%
|
-19,244.53%
|
-23,671.57%
|
-6,049.2%
|
-5,860.46%
|
-4,378.43%
|
-5,066.46%
|
-3,565.29%
|
-4,877.81%
|
-1,627.08%
|
-958.42%
|
-538.33%
|
-492.31%
|
-311.11%
|
EPS
2 |
-0.1500
|
-0.1400
|
-0.1400
|
-0.1400
|
-0.1300
|
-0.1500
|
-0.1400
|
-0.1100
|
-0.1100
|
-0.1000
|
-0.0975
|
-0.0900
|
-0.0850
|
-0.0700
|
-0.0600
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
30/03/22
|
11/05/22
|
10/08/22
|
14/11/22
|
15/03/23
|
10/05/23
|
14/08/23
|
14/11/23
|
25/03/24
|
13/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
13.4
|
-
|
-
|
-
|
-
|
4.4
|
25.9
|
30.3
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-18.4
|
-21.8
|
-
|
-
|
-27.2
|
-13.7
|
5.3
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
0.3500
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
0.51
|
1.94
|
0.97
|
-
|
-
|
0.77
|
1.73
|
3.3
|
Capex / Sales
|
2,989.88%
|
14,453.16%
|
1,081.25%
|
-
|
-
|
26.85%
|
12.86%
|
8.1%
|
Announcement Date
|
20/02/20
|
22/03/21
|
30/03/22
|
15/03/23
|
25/03/24
|
-
|
-
|
-
|
Last Close Price
0.6926
USD Average target price
3.467
USD Spread / Average Target +400.53% Consensus |
1st Jan change
|
Capi.
|
---|
| -3.40% | 5.74Cr | | +17.71% | 389.62Cr | | +4.92% | 238.7Cr | | -19.94% | 201.42Cr | | -19.77% | 168.72Cr | | +20.31% | 104.67Cr | | +27.42% | 80Cr | | -9.83% | 70Cr | | -29.39% | 51Cr | | -6.96% | 27Cr |
Bio Diagnostics & Testing
|